Technology | April 17, 2015

Cerner and Qualcomm Collaborate on Home Health Monitoring Network

Qualcomm's 2net Platform will capture patient data from home, transmit it via Cerner's CareAware platform

Cerner, Qualcomm, home health monitoring, 2net, CareAware, EHR

April 17, 2015 — Cerner Corp. and Qualcomm Life Inc. announced an agreement to extend Cerner’s medical device connectivity capabilities beyond the hospital to the home. Cerner will leverage Qualcomm Life’s U.S. Food and Drug Administration (FDA)-listed 2net Platform and Hub to capture data from medical devices and sensors within a patient’s home, and transmit it to Cerner healthcare clients through Cerner’s CareAware device connectivity platform. Through this initiative, care providers can remotely monitor chronically ill patients in near-real time to enable proactive engagement to potentially reduce the risk of an acute care episode.

Qualcomm Life’s 2net Platform collects, stores and aggregates patient data from connected medical devices provided to the patient, such as weight scales, blood pressure monitors and pulse oximeters. These data values will transmit via CareAware to the Cerner Millennium electronic health record (EHR) and are viewable to the patient in HealtheLife, Cerner’s patient engagement solution. Extending CareAware to integrate devices within the home to the patient’s EHR will provide healthcare organizations a more comprehensive view in their efforts to focus on chronic condition management, reduce readmissions and improve patient health and satisfaction.

Qualcomm Life will join Cerner’s CareAware certification program, an initiative that creates alliances between Cerner and medical device manufacturers to better acquire data from devices to integrate with the EHR via CareAware device connectivity architecture.

Agnesian HealthCare is one of the first enterprise clients to implement the combined technologies to remotely monitor and manage at-risk patient populations. “It is increasingly important that providers are monitoring the whole health of an individual, not just at the point of care in the facility,” said Michael DeGeer, DPM, FACPS, FACFAS, vice president of population health management, Agnesian HealthCare. “Remote patient monitoring allows our clinicians to have access to patients’ health data, within the patient’s health record, while they are at home, which will provide the opportunity for clinicians to make informed interventions as needed.”

For more information: www.cerner.com, www.qualcommlife.com


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now